Key Information
Source
Alnylam Pharmaceuticals, Inc.
Year
2020
summary/abstract
Consider genetic testing and counseling for your patients; Alnylam Act(R) provides one option for eligible individuals.
What Is Alnylam Act(R)?
Alnylam Act(R) is a sponsored, no-charge, third-party genetic testing and counseling program for patients with a family history or suspected diagnosis of hATTR amyloidosis. The Alnylam Act(R) program was developed to reduce barriers to genetic testing and counseling to help people make more informed decisions about their health.
What Genes Are Tested Through Alnylam Act(R)?
Genetic testing for hATTR amyloidosis can be ordered through a single gene test for the TTR gene or as part of larger panels. The larger panels test for changes in the TTR gene as well as for changes in other genes associated with hereditary conditions that may have overlapping symptoms with hATTR amyloidosis.
Abstract Source
https://www.alnylam.com/wp-content/uploads/pdfs/Alnylam_Act_hATTR_Provider.pdf